Seroprevalence of Antibodies to Measles, Mumps and Rubella in Thai Adolescents

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20191120001

Enrollment

450

Registered

2019-11-20

Start date

2020-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measles disease Mumps disease Rubella disease Seroprevelence Measles Mumps Rubella Thai Adolescents

Interventions

Thai adolescents age 10&#45

18 years

No Intervention Other

Thai adolescents

Eligibility

Sex/Gender

All

Age

9 Years to 18 Years

Inclusion criteria

Inclusion criteria: Informed consents Unremarkable medical history and physical examination

Exclusion criteria

Exclusion criteria: Immunocompromised host Received MMR vaccination after aged of 7 years Received blood product within 3 months Received immunosuppressive agents within 3 months

Design outcomes

Primary

Measure	Time frame
Seroprevalence of Antibodies to Measles Virus in adolescents 1 month after complete recruitment Measles antibody by Elisa test	—

Secondary

Measure	Time frame
Seroprevalence of Antibodies to Mumps and Rubella Virus in adolescents 1 month after complete recruitment Mumps and Rubella antibody by Elisa test	—

Countries

Thailand

Contacts

Public ContactPiyada Angsuwatcharakon

King Chulalongkorn Memorial Hospital

Piyada.angs@gmail.com086-8946633

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Seroprevalence of Antibodies to Measles&#44; Mumps and Rubella in Thai Adolescents